SCHEMBL4789300

SCHEMBL4789300

Nc1c(C(=O)O)nnn1-c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.69
HTT P42858 1/20 0.65
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
HPGD P15428 2/20 0.55
GAA P10253 1/20 0.50
LMNA P02545 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALOX12 P18054 1/20 0.48
KDM4E B2RXH2 1/20 0.47
RIPK2 O43353 1/20 0.46
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA4 P22748 1/20 0.45
CA9 Q16790 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12088095 0.86 TP53 (0.70) TP53HTTNPC1RAB9ASMN1; SMN2
SCHEMBL11349132 0.85 CA1 (0.56) TP53HTTNPC1RAB9ASMN1; SMN2
SCHEMBL14692564 0.84 ALDH1A1 (0.53) TP53HTTNPC1RAB9ASMN1; SMN2
SCHEMBL10983744 0.82 TP53 (1.00) TP53HTTNPC1RAB9ASMN1; SMN2
SCHEMBL10986951 0.79 TP53 (0.68) TP53HTTNPC1RAB9ASMN1; SMN2
SCHEMBL1753520 0.79 TP53 (0.75) TP53HTTNPC1RAB9ASMN1; SMN2
SCHEMBL4771303 0.79 HTT (1.00) TP53HTTGAALMNAKMT2A
SCHEMBL4487634 0.77 KDM4E (0.72) TP53HTTSMN1; SMN2GAAMEN1
SCHEMBL18172023 0.77 MAPT (0.57) TP53HTTHPGDGAALMNA
SCHEMBL10972562 0.76 TP53 (0.57) TP53HTTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130321-A2 NOVEL N-TETRAHYDRONAPHTALENE OR 5-HETEROCYCLYL-CHROMANE OR 8-HETEROCYCLYL-TETRAHYDRONAPHTALENE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO disclosed